Exponent (NASDAQ:EXPO) vs. Nukkleus (NASDAQ:NUKK) Financial Review

Exponent (NASDAQ:EXPO) and Nukkleus (NASDAQ:NUKK) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Analyst Recommendations

This is a summary of current ratings for Exponent and Nukkleus, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0	1	1	0	2.50
Nukkleus	0	0	0	0	N/A

Exponent presently has a consensus price target of $97.00, indicating a potential upside of 20.35%. Given Exponent’s higher possible upside, equities research analysts clearly believe Exponent is more favorable than Nukkleus.

Risk & Volatility

Exponent has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Nukkleus has a beta of -0.32, meaning that its stock price is 132% less volatile than the S&P 500.

Institutional and Insider Ownership

92.4% of Exponent shares are held by institutional investors. Comparatively, 12.5% of Nukkleus shares are held by institutional investors. 2.2% of Exponent shares are held by company insiders. Comparatively, 69.8% of Nukkleus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Exponent and Nukkleus’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Exponent	18.69%	28.49%	16.58%
Nukkleus	N/A	N/A	-4.47%

Earnings & Valuation

This table compares Exponent and Nukkleus’ revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$536.77 million	7.59	$100.34 million	$1.95	41.33
Nukkleus	$22.37 million	0.07	-$970,000.00	N/A	N/A

Exponent has higher revenue and earnings than Nukkleus.

Summary

Exponent beats Nukkleus on 10 of the 11 factors compared between the two stocks.

About Exponent

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

About Nukkleus

Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. The company primarily offers software, technology, customer sales and marketing, and risk management technology hardware and software solutions. It also offers payment services from one fiat currency to another or to digital assets. The company was founded in 2013 and is headquartered in Jersey City, New Jersey. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd.